Non-invasive, quantitative assessment of the anatomical phenotype of corticotropin-releasing factor-overexpressing mice by MRI

被引:11
作者
Beckmann, N
Gentsch, C
Baumann, D
Bruttel, K
Vassout, A
Schoeffter, P
Loetscher, E
Bobadilla, M
Perentes, E
Rudin, M
机构
[1] Novartis Pharma AG, Core Technol Area, CH-4002 Basel, Switzerland
[2] Novartis Pharma AG, Nervous Syst Dept, CH-4002 Basel, Switzerland
[3] Novartis Pharma AG, Dept Toxicol, CH-4002 Basel, Switzerland
关键词
corticotropin-releasing factor (CRF); magnetic resonance imaging (MRI); microimaging; transgenic mouse; stress;
D O I
10.1002/nbm.704
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
High resolution magnetic resonance imaging (MRI) was applied to quantify alterations in thymus and adrenal volumes, as well as body fat in genetically engineered corticotropin-releasing factor (CRF)-overexpressing mice. When compared to the organs in age-matched wild-type animals, the adrenals in CRF-overexpressing male mice were significantly enlarged and the thymus volume in females was significantly smaller. The fat content was significantly larger in CRF-overexpressing mite. The anatomical alterations observed in the MRI studies were in perfect line with post-mortem data (weights of organs). Furthermore, the observed interstrain differences are in agreement with recently published data on (i) the effect of continuous, intraventricular infusion of CRF in rats and (ii) the presence of atrophic adrenals in CRF-knockout mice. The present studies demonstrate that MRI can provide reliable measures of relatively small structures such as the adrenal glands and the thymus in mice. This makes MRI an attractive, non-terminal tool to monitor in laboratory animals, including transgenic mice, the consequence of continuous stress on relevant organs. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:210 / 216
页数:9
相关论文
共 27 条
[1]   From anatomy to the target: Contributions of magnetic resonance imaging to preclinical pharmaceutical research [J].
Beckmann, N ;
Mueggler, T ;
Allegrini, PR ;
Laurent, D ;
Rudin, M .
ANATOMICAL RECORD, 2001, 265 (02) :85-100
[2]   Behavioral and endocrine change following chronic predatory stress [J].
Blanchard, RJ ;
Nikulina, JN ;
Sakai, RR ;
McKittrick, C ;
McEwen, B ;
Blanchard, DC .
PHYSIOLOGY & BEHAVIOR, 1998, 63 (04) :561-569
[3]   Physiological and behavioral effects of chronic intracerebroventricular infusion of corticotropin-releasing factor in the rat [J].
Buwalda, B ;
deBoer, SF ;
VanKalkeren, AA ;
Koolhaas, JM .
PSYCHONEUROENDOCRINOLOGY, 1997, 22 (05) :297-309
[4]  
Camera L, 1999, ANN MED, V31, P57
[5]   Thymotrophic effect of ether lipid 1-O-octadecyl-2-O-methoxy-rac-glicero-3-phosphocholine in the mouse [J].
Cardile, V ;
Mudo, G ;
Jiang, XH ;
Casella, F ;
Bindoni, M ;
Belluardo, N .
IMMUNOPHARMACOLOGY, 1997, 37 (2-3) :199-207
[6]   Understanding corticotropin releasing factor neurobiology: contributions from mutant mice [J].
Contarino, A ;
Heinrichs, SC ;
Gold, LH .
NEUROPEPTIDES, 1999, 33 (01) :1-12
[7]  
GRIGORIADIS DE, 1998, P NEUR WORKSH STRESS, P26
[8]   Defeat is a major stressor in males while social instability is stressful mainly in females:: Towards the development of a social stress model in female rats [J].
Haller, J ;
Fuchs, E ;
Halász, J ;
Makara, GB .
BRAIN RESEARCH BULLETIN, 1999, 50 (01) :33-39
[9]  
KOOB GF, 1993, CIBA F SYMP, V172, P277
[10]   BEHAVIORAL AND CARDIAC RESPONSES AFTER INTRACEREBROVENTRICULAR CORTICOTROPIN-RELEASING HORMONE (CRH) ADMINISTRATION - ROLE OF ADRENAL-CORTICAL HORMONES [J].
KORTE, SM ;
EISINGA, W ;
TIMMERMAN, W ;
NYAKAS, C ;
BOHUS, B .
HORMONES AND BEHAVIOR, 1992, 26 (03) :375-384